CD20xCD3 | Friends of Cancer Research

You are here

CD20xCD3

Sponsor: 
F. Hoffmann-La Roche AG
Indication: 
Treatment of adult patients with relapsed or refractory (R/R) follicular lymphoma who have received at least two prior systemic therapies
Category: 
Year: 
2020
Date: 
Jul 14th
FDA Status: 
Designation Granted